These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor. Duncan M; Millns P; Smart D; Wright JE; Kendall DA; Ralevic V Br J Pharmacol; 2004 Jun; 142(3):509-18. PubMed ID: 15148262 [TBL] [Abstract][Full Text] [Related]
23. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. Khasabova IA; Khasabov S; Paz J; Harding-Rose C; Simone DA; Seybold VS J Neurosci; 2012 May; 32(20):7091-101. PubMed ID: 22593077 [TBL] [Abstract][Full Text] [Related]
24. Cannabinoid system involves in the analgesic effect of protocatechuic acid. Dikmen DY; Okcay Y; Arslan R; Bektas N Daru; 2019 Dec; 27(2):605-612. PubMed ID: 31325037 [TBL] [Abstract][Full Text] [Related]
25. Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention. Álvarez-Tosco K; González-Fernández R; González-Nicolás MÁ; Martín-Ramírez R; Morales M; Gutiérrez R; Díaz-Flores L; Arnau MR; Machín F; Ávila J; Lázaro A; Martín-Vasallo P BMC Neurosci; 2024 Sep; 25(1):44. PubMed ID: 39278931 [TBL] [Abstract][Full Text] [Related]
26. Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Ta LE; Bieber AJ; Carlton SM; Loprinzi CL; Low PA; Windebank AJ Mol Pain; 2010 Mar; 6():15. PubMed ID: 20205720 [TBL] [Abstract][Full Text] [Related]
27. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain. Pol O; Murtra P; Caracuel L; Valverde O; Puig MM; Maldonado R Neuropharmacology; 2006 Jan; 50(1):123-32. PubMed ID: 16360182 [TBL] [Abstract][Full Text] [Related]
28. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Rahn EJ; Makriyannis A; Hohmann AG Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696 [TBL] [Abstract][Full Text] [Related]
29. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279 [TBL] [Abstract][Full Text] [Related]
30. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Renn CL; Carozzi VA; Rhee P; Gallop D; Dorsey SG; Cavaletti G Mol Pain; 2011 Apr; 7():29. PubMed ID: 21521528 [TBL] [Abstract][Full Text] [Related]
31. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373 [TBL] [Abstract][Full Text] [Related]
32. Antihyperalgesic effect of CB Oliveira-Fusaro MCG; Zanoni CIS; Dos Santos GG; Manzo LP; Araldi D; Bonet IJM; Tambeli CH; Dias EV; Parada CA Eur J Pharmacol; 2017 Mar; 798():113-121. PubMed ID: 28131783 [TBL] [Abstract][Full Text] [Related]
34. Resveratrol exerts anti-oxidant and anti-inflammatory actions and prevents oxaliplatin-induced mechanical and thermal allodynia. Recalde MD; Miguel CA; Noya-Riobó MV; González SL; Villar MJ; Coronel MF Brain Res; 2020 Dec; 1748():147079. PubMed ID: 32866545 [TBL] [Abstract][Full Text] [Related]
35. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system. Romero TR; Resende LC; Guzzo LS; Duarte ID Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980 [TBL] [Abstract][Full Text] [Related]
36. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy. Nasirinezhad F; Jergova S; Pearson JP; Sagen J Neuropharmacology; 2015 Aug; 95():100-9. PubMed ID: 25486617 [TBL] [Abstract][Full Text] [Related]
37. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy. Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184 [TBL] [Abstract][Full Text] [Related]